Cargando…

The Protective Function of PRMT1 in Alcohol‐Induced Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Jeong, Jong‐Min, Ju, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262288/ https://www.ncbi.nlm.nih.gov/pubmed/32490316 http://dx.doi.org/10.1002/hep4.1527

Ejemplares similares

The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma
por: Wright, Tanner, et al.
Publicado: (2021)

Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses
por: Zhao, Jie, et al.
Publicado: (2019)

PRMT5 inhibitors on the (myeloma) road
por: Gulla, Annamaria, et al.
Publicado: (2018)

Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes
por: Liu, Liwen, et al.
Publicado: (2023)

Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
por: Dashti, Parisa, et al.
Publicado: (2023)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
por: Shim, Ju Hyun
Publicado: (2020)

Structure, Activity, and Function of PRMT1
por: Thiebaut, Charlène, et al.
Publicado: (2021)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

PRMT1 loss sensitizes cells to PRMT5 inhibition
por: Gao, Guozhen, et al.
Publicado: (2019)

PRMT1 suppresses ATF4-mediated endoplasmic reticulum response in cardiomyocytes
por: Jeong, Myong-Ho, et al.
Publicado: (2019)

Correction: PRMT1 suppresses ATF4-mediated endoplasmic reticulum response in cardiomyocytes
por: Jeong, Myong-Ho, et al.
Publicado: (2020)

Prmt5 differentiates developmental vs regenerative myogenesis
por: Zhang, Ting, et al.
Publicado: (2015)

An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression
por: Shen, Ting, et al.
Publicado: (2022)

PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma
por: Wang, Kui, et al.
Publicado: (2023)

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
por: Kim, Jin-Wook
Publicado: (2010)

PRMT1 and PRMT4 Regulate Oxidative Stress-Induced Retinal Pigment Epithelial Cell Damage in SIRT1-Dependent and SIRT1-Independent Manners
por: Kim, Dong-Il, et al.
Publicado: (2015)

PRMT5 function and targeting in cancer
por: Kim, Hyungsoo, et al.
Publicado: (2020)

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Teng, Margaret L. P., et al.
Publicado: (2022)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
por: Teng, Margaret LP, et al.
Publicado: (2023)

PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2016)

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
por: Choi, Joo-Hee, et al.
Publicado: (2018)

The Methyltransferases PRMT4/CARM1 and PRMT5 Control Differentially Myogenesis in Zebrafish
por: Batut, Julie, et al.
Publicado: (2011)

Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α
por: Zheng, Bai-Nan, et al.
Publicado: (2019)

Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6
por: Sivakumaran, Haran, et al.
Publicado: (2013)

Prmt5: a guardian of the germline protects future generations
por: Berrens, Rebecca V, et al.
Publicado: (2015)

PRMT1 inhibition induces differentiation of colon cancer cells
por: Plotnikov, Alexander, et al.
Publicado: (2020)

Metadherin–PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT–β-catenin signaling pathway
por: Zhu, Kai, et al.
Publicado: (2020)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis
por: Du, Peng, et al.
Publicado: (2021)

The Structure and Functions of PRMT5 in Human Diseases
por: Motolani, Aishat, et al.
Publicado: (2021)

Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease
por: Gallo, Paolo, et al.
Publicado: (2023)

Protection of c-Fos from autophagic degradation by PRMT1-mediated methylation fosters gastric tumorigenesis
por: Kim, Eunji, et al.
Publicado: (2023)

Surveillance of hepatocellular carcinoma: is only ultrasound enough?
por: Jeong, Woo Kyoung
Publicado: (2017)

The protective effect of PRMT6 overexpression on cigarette smoke extract-induced murine emphysema model
por: He, Xue, et al.
Publicado: (2017)

UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients
por: Madreiter-Sokolowski, Corina T., et al.
Publicado: (2017)

Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective
por: Díaz, Luis Antonio, et al.
Publicado: (2022)

PRMT1 methylates METTL14 to modulate its oncogenic function
por: Wang, Jingchao, et al.
Publicado: (2023)

Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4)
por: Gunnell, Emma A., et al.
Publicado: (2020)

PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma
por: Jiang, Hai, et al.
Publicado: (2018)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
por: Du, Peng, et al.
Publicado: (2022)

PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast
por: Zhi, Renyong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uq7resgc4sm95g1ujikr5igrg2